A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury

Molecular Diagnosis and Therapy

Volumn 16, Issue 2, 2012, Pages 79-92

  Schiff, Leora ^a   Hadker, Nandini ^a   Weiser, Silvia ^b   Rausch, Carsten ^c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c Roche Diagnostics Ltd   (Switzerland)

Author keywords

Biomarkers; Brain injuries; Diagnostic assays; Stroke

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GLASGOW OUTCOME SCALE; HUMAN; INJURY SCALE; INTRACRANIAL PRESSURE; MEAN ARTERIAL PRESSURE; MOLECULAR PATHOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; STROKE; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN INJURY;

EID: 84859792503     PISSN: 11771062     EISSN: 11792000     Source Type: Journal    
DOI: 10.1007/bf03256432     Document Type: Review

References (33)

1. Chestnut RM, Ghajar J, Maas AIR, et al. Early indicators of prognosis in severe traumatic brain injury. New York: Brain Trauma Foundation, 2009 Oct [online]. Available from: http://www.braintrauma.org/pdf/protected/ prognosis-guidelines.pdf [Accessed 2012 Mar 14]
2. Jager TE, Weiss HB, Coben JH, et al. Traumatic brain injuries evaluated in U.S. emergency departments, 1992-1994. Acad Emerg Med 2000 Feb; 7 (2): 134-40 (Pubitemid 30084644)
3. Rutland-Brown W, Langlois JA, Thomas KE, et al. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 2006 Nov- Dec; 21 (6): 544-8 (Pubitemid 44813644)
4. Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J Head Trauma Rehabil 2006 Jul-Aug; 21 (4): 315-33 (Pubitemid 44258961)
5. Jagoda AS, Bazarian JJ, Bruns Jr JJ, et al. Clinical policy: neuroimaging and decisionmaking in adult mild traumatic brain injury in the acute setting. Ann Emerg Med 2008 Dec; 52 (6): 714-48
6. Hergenroeder GW, Redell JB, Moore AN, et al. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther 2008; 12 (6): 345-58 (Pubitemid 352790449)
7. Nylén K, Csajbok LZ, Ost M, et al. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 2007 May; 38 (5): 1489-94 (Pubitemid 46684150)
8. Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiatry 1996 Apr; 60 (4): 362-9 (Pubitemid 26118740)
9. National Center for Health Statistics, Centers for Disease Control and Prevention. National hospital ambulatory medical care survey: emergency department file (2002). CD-ROM series 13, no. 33. Atlanta (GA): National Center for Health Statistics, Centers for Disease Control and Prevention, 2000
10. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 2008 Aug 5; 5 (8): e165; discussion e165
11. Langlois J, Rutland-Brown W, Thomas KE. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, 2004
12. American Heart Association. About stroke [online]. Available from URL: http://www.strokeassociation.org/STROKEORG/AboutStroke/About-Stroke-UCM-308529- SubHomePage.jsp [Accessed 2011 Nov 11, 2011]
13. Centers for Disease Control and Prevention. Vital statistics data available online. Mortality multiple cause files: 2008 [online]. Available from URL: http://www.cdc.gov/nchs/data-access/Vitalstatsonline.htm#Mortality-Multiple [Accessed 2011 Sep 23]
14. Hill MD. Diagnostic biomarkers for stroke: a stroke neurologist's perspective. Clin Chem 2005 Nov; 51 (11): 2001-2 (Pubitemid 41532613)
15. Foerch C, Curdt I, Yan B, et al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry 2006 Feb; 77 (2): 181-4 (Pubitemid 43220838)
16. Korfias S, Papadimitriou A, Stranjalis G, et al. Serum biochemical markers of brain injury. Mini Rev Med Chem 2009 Feb; 9 (2): 227-34
17. Vissers JL, Mersch ME, Rosmalen CF, et al. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum. Clin Chim Acta 2006 Apr; 366 (1-2): 336-40 (Pubitemid 43331005)
18. Missler U, Wiesmann M, Wittmann G, et al. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. Clin Chem 1999 Jan; 45 (1): 138-41 (Pubitemid 29036401)
19. Petzold A, Keir G, Green AJ, et al. An ELISA for glial fibrillary acidic protein. J Immunol Methods 2004 Apr; 287 (1-2): 169-77 (Pubitemid 38510218)
20. Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006 Oct; 13 (10): 1118-23 (Pubitemid 44434318)
21. Centre for Evidence Based Medicine [CEBM]. Oxford Centre for Evidence- Based Medicine - levels of evidence. Oxford: CEBM, 2009 Mar [online]. Available from URL: http://www.cebm.net/index.aspx?o=1025 [Accessed 2012 Feb 21]
22. Honda M, Tsuruta R, Kaneko T, et al. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma 2010 Jul; 69 (1): 104-9
23. Lumpkins KM, Bochicchio GV, Keledjian K, et al. Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 2008 Oct; 65 (4): 778- 82; discussion 782-4
24. Nylén K, Ost M, Csajbok LZ, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci 2006 Jan 15; 240 (1-2): 85-91 (Pubitemid 41814959)
25. Pelinka LE, Kroepfl A, Schmidhammer R, et al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004 Nov; 57 (5): 1006-12 (Pubitemid 39579285)
26. Wiesmann M, Steinmeier E, Magerkurth O, et al. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand 2010 Mar; 121 (3): 178-85
27. Dvorak F, Haberer I, Sitzer M, et al. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis 2009; 27 (1): 37-41
28. Unden J, Strandberg K, Malm J, et al. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. J Neurol 2009 Jan; 256 (1): 72-7
29. Vos PE, van Gils M, Beems T, et al. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol 2006 Jun; 13 (6): 632-8 (Pubitemid 43873636)
30. Pelinka LE, Kroepfl A, Leixnering M, et al. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 2004 Nov; 21 (11): 1553-61 (Pubitemid 39525165)
31. Vos PE, Jacobs B, Andriessen TM, et al. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Neurology 2010 Nov 16; 75 (20): 1786-93
32. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004 Apr 27; 62 (8): 1303-10 (Pubitemid 38526041)
33. Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem 2012 Jan; 58 (1): 237-45